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Background: With the advents of new processing techniques and new graft survival theories 
in fat grafting, the question is: Which processing technique is of preference? This study 
systematically reviewed literature regarding current techniques for processing fat grafts.
Methods: PubMed, Embase, Cinahl, and Cochrane databases were searched until August 
2015. Studies comparing different fat grafting processing techniques were included. Outcomes 
were viability of adipocytes, number of adipose-derived stromal/stem cells (ASC) and growth 
factors in vitro, volume and quality of the graft in animal studies, and satisfaction and volume 
retention in human studies.
Results: Thirty-five studies were included. Adipocyte viability and ASC numbers were the best 
using the gauze/towel technique (permeability principle) compared to centrifugation. With 
regard to centrifugation, the pellet contained more ASCs compared to the middle layer. The 
animal studies’ and patients’ satisfaction results were not distinctive. The only study assessing 
volume retention in humans showed that a wash-filter device performed significantly better 
than centrifugation.
Conclusion: Processing techniques using permeability principals prove superior to 
centrifugation (reinforced gravity principle) regarding viability and ASC number. Due to 
the variety in study characteristics and reported outcome variables, none of the processing 
techniques demonstrate any clinical evidence.
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INTRODUC TION
Autologous fat transplantation (AFT) is a commonly applied procedure in reconstructive and 
aesthetic surgery.1 Autologous subcutaneous fat is abundantly available in most patients, fully 
biocompatible and conceivably permanent.2 AFT is used for facial rejuvenation and correction 
of volume deficiencies caused by trauma3, congenital malformations4, or after surgical 
procedures2. Moreover, AFT has been used increasingly for skin regeneration, e.g., in the case 
of burns and scars.5
Even though AFT has been performed for decades, no consensus exists about the best fat 
grafting technique.6,7 Amongst others, location of donor sites, use of local anesthetics, 
harvesting methods, processing techniques, and injection techniques continue to be points of 
discussion.6,8,9 Most studies analyzed the effects of fat processing techniques on adipocyte 
viability.6 Currently used processing techniques are based on centrifugation, sedimentation, 
filter, or washing principles.7,9 Recent theories focus more on the crucial role of adipose-
derived stromal/stem cells (ASC)10 and/or growth factors like vascular endothelial grow 
factor (VEGF)11,12 in fat graft survival rather than adipocyte viability. These theories give the 
current literature another perspective.
This systematic review analyzed the effects of current processing techniques of fat grafting on 
adipocyte viability, levels of ASCs and growth factors in vitro, volume and quality of grafts in 
animals, as well as volume retention and patients’ satisfaction in humans.
MATERIAL AND ME THODS
Information sources and search
PubMed, Embase, Cochrane Central Register of controlled trials, and Cinahl electronic 
databases were searched (last search August, 10th 2015).  Keywords used for the search were 
“fat graft”, “fat transfer”, “lipofilling”, “autologous fat transplantation”, or “subcutaneous fat 
transplant” in combination with either “processing”, “harvesting”, “centrifugation”, “gauze”, 
“mesh”, “towel”, “wash”, “sieve”, “sedimentation”, or “decantation” (Appendix 1). The 
reference lists of the selected articles were screened for relevant studies missed in the search.
Eligibility criteria
Papers were eligible if at least 2 different types of fat graft processes were compared or 1 
process was compared to a control group without a processing procedure. In vitro, animal, 
and human studies were included when studies assessed adipocyte viability, ASC levels, 
stromal vascular fraction (SVF) yield, or growth factors in vitro, the volume and quality of grafts 
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in animals, or the volume retention and patients’ satisfaction in humans. Studies focusing on 
methods other than processing of the harvested lipoaspirate were excluded. Moreover, studies 
were rejected when different harvesting techniques were used between study groups within a 
study or when additional growth factors, SVF, or ASCs were added to the lipoaspirate. Case 
series (n<5), case-reports, and expert reviews were also excluded. No language restrictions 
were applied.
Assessment of quality of included studies
The methodological quality of the included studies was assessed using the criteria of the 
modified Methodological Index of Nonrandomized Studies (MINORS).13 Table 1 describes 
the specific assessment criteria of the studies, specified for the current study. The authors (AJT, 
PD) predefined a MINORS score of ≤6 as being of insufficient quality; those studies were 
excluded for analysis.
Table 1. Individual MINORS criteria explained
1. Aim Clearly stated aim. Comparison and endpoints need to be mentioned.
2. Inclusion Clear inclusion and exclusion criteria of subjects.
3. Collection Prospective collection of data. Protocol established 
before the beginning of the study
4. Endpoints Endpoints need to be in accordance with the question/
aim of the study. Endpoints need to be clearly stated.
5. Unbiased assessment Any form of blinding (double blind or single blind).
6. Follow up Follow up period is sufficiently long to allow the assessment 
of the endpoints. In vitro studies = directly; In vivo > 28 
days; In vivo “long term” endpoint >10 months. 
7. Loss to follow up All patients should be included in a follow up. 
Follow up loss may not exceed 5%.
8. Prospective calculation 
of the study size
A sample size calculation is performed before the start of the study. 
9. Adequate control group The control group should have a gold standard. In this 
assessment any form of centrifugation is 1 point.
10. Contemporary groups Control and studied groups are managed for  the 
same time period (no historical comparison).
11. Baseline equivalence Study groups are similar . No confounding factors. Fat from same 
person, or age/gender matched fat donors/receivers. 
12. Statistical analysis Adequate reported statistical analysis.
* The items are scored 0 (not reported or reported inadequately) or 1 (reported and adequate). The ideal score for comparative 
studies is 12.
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Study selection
Study selection and quality assessment was done by two observers independently (AJT, 
PND). Disagreement was discussed during a consensus meeting. In the case of a persistent 
disagreement, an independent observer (AV) gave a binding verdict.
Data items
Processing techniques used in the included studies were categorized according to the following 
conditions: “centrifugation”, “decantation”, “gauze/towel”, “devices”, “metal sieve”, “wash”, 
“wash and centrifugation”, and “negative control” (Table 2).
Table 2. Description of the processing categories
Processing 
categories Code* Principle Further explanation 
Centrifugation c Reinforced 
Gravity
Any time or g-force centrifugation. Distinct 
different layers in the aspirate.
Decantation d Gravity Minimum of 2 minutes of decantation (sedimentation). 
Distinct different layers in the aspirate. 
Device dv Wash, 
Permeability, 
(Gravity)
Using a manufactured device intended for fat grafting. 
Including devices for harvesting and processing in one. 
Gauze/towel g Gravity, 
Permeability
Any technique using the principle of gravity through 
a gauze, mesh gauze or towel (fabric).
Metal sieve s Gravity, 
Permeability
Technique using the principle of gravity 
through a metal sieve.






Combination of washing and centrifugation 
(any time, any g-force).
Negative control n - No treatment. No distinct different layers. 
Outcomes
Studies were classified based on their outcome in vitro, in animals, and/or in humans. In vitro 
studies analyzed adipocyte viability, number ASC or SVF yield, and growth factors. Animal 
studies focused on volume retention (or graft weight) and/or histologic findings in transplanted 
grafts such as cysts, inflammation, fibrosis, vascularization, and/or integrity. Human studies 





Intra observer agreement for MINORS assessment was calculated by an absolute agreement 
score and a Cohen’s kappa.
Publication bias of included studies
Publication bias could affect the results of this review. It might be more beneficial for research 
groups with an interest in processing devices to only publish studies with positive results of their 
devices. Devices were split into another subcategory in the data analysis.
Synthesis of centrifugal forces
Centrifugal forces can be displayed in revolutions per minute or g-force. Thus, to compare 
centrifugal forces of different studies, the relative centrifugal force (RCF) was used. If centrifugal 
forces were given in revolutions per minute (rpm), the RCF was calculated by the first author with 
the following formula14: RCF (in xg) =1.12*10-5 * r * rpm2. This calculation means the articles 




In total, 401 papers were identified (Figure 1). After abstract-screening, 45 full-text studies 
remained and were assessed for eligibility. Three studies were excluded on the basis of the 
lack of comparison of at least two separate processing methods.15-17 One study was excluded 
because other factors were added to the aspirate.18 Two studies did not report an outcome of 
interest.19,20 Thus, 38 studies remained for further analysis.
MINORS assessment of study quality
MINORS scores ranged from 12 to 5 (Appendix 2). All studies had a prospective collected 
study population, but only one study used a historical control group. Six studies reported blinded 
assessment of their results. Just 42% of the studies described their inclusion criteria properly. 
Three studies did not pass the minimum MINORS assessment score and were not analyzed 
further.21-23 Thirty five studies were of sufficient methodological quality and thus compared. The 
absolute agreement of the MINORS score of the individual components between observers 
was 95%. The Cohen’s kappa was 0.872 (p<0.001).
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Figure 1. Flow diagram of study selection
Studies’ characteristics
Of the 35 studies, two studies only analyzed processed animal fat lipoaspirate in vitro and 17 
studies only analyzed processed human fat lipoaspirate in vitro (Table 3). Eight studies described 
processed human fat graft transplantation to animals and eight studies described a processed 
human fat graft transplantation to humans. Some of these in vivo studies (n=8) performed 
additionally an in vitro analysis of the processed lipoaspirate. Of the 26 studies in which 
gender was reported, 86% of the population was female (n=363 females). The characteristics 
of the study population, and infiltration and harvesting techniques are summarized in Table 4. 
Only descriptive analyses were performed since outcome variables and methods proved to be 
too diverse for other analysis. No meta-analyses could be conducted.
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Table 3. Characteristics of the included studies according to study design
























































































































Animal processed fat  in vitro
Gonzalez 2007 8 ws V 5 rats . . AFT f  + R . . . 2;3 . 10/20/60 x neg d, g
Piasecki 2007 7 ws V x mice . . LS t . . . . . 1.2 . 5 5cc neg c (8x), d, g
Human processed fat  in vitro
Boschert 2002 8 ws V 20 (16) . 27-49 LS a,f,h,k,t . . . . . 2.0/3.0/5.0 Mercedes sp sp c (4x)
Huss 2002 8 ws V 8 (.) . . LS a,b . . . . . 5.0/6.0 Toomey 50 . w, wc
Rohrich 2004 8 ws V 5 (.) . . . a,f,k,t  + . . . . . Coleman 10 . c, n
Rose 2006 9 bs V 22 (.) . . AFT  a  + NaCl 50ml 1% 1 ml 1:000  + . Coleman 10 manual c, d
Kim 2009 8 ws V 8 (.) 32 (6) . LS a  + HS 20ml 2% 0.5ml 0.1%  - 1.2 Coleman . . c (8x), n
Conde-Green, b 2010 10 ws V 20 (20) . 28-64 LS a  + NaCl 1: 500 000  - 3.0 Richter 10 manual c, d, w
Conde-Green, a 2010 9 ws V 10 (10) . 35-58 LS a  + NaCl 1: 500 000  - 3.0 10 . c, d 
Herold 2011 8 ws V 9(5) 40 (.) 14-74 LS a,b,h  + NaCl 1ml 1:1000  + 3.0 Coleman → TT →-0.38 atm c, dv, n
→ 10 → <2cc neg c, dv, n
Pulsfort 2011 8 ws V 13 (11) 47 (11) . AFT/LS .  + NaCl 12.5ml 1% b 1:200 000  - 2.0 Coleman 10 . c (7x), n
Duman 2013 7 ws V . . . LS a  + NaCl 1:500 000  - . Lipokit 50 sp d, dv
Zhu 2013 10 ws V 22 (22) 45 (12) 24-64 . a,f,h . . . . . . . . . c, d, dv, n
Kamel 2014 8 ws V 20 (20) 31 (1) 20-41 LS a,t  + R 30ml 1% 1mg  - 3.0 60 → manual c, g
→ 2-3 atm c, g
Pfaff 2014 8 ws V 5 (3) 38 (24) 12-68 . a  + 10ml 1% 1:100 000  - . . 10 manual c, g
Iyyanki 2015 8 ws V 19(19) 51(10) 41-61 AFT Breast a, b, f . . . . . 3.0 Coleman 10 manual c, n
Osinga 2015 8 ws V 6(3) . . LS a + NaCl 0.91mg/ml 1.8µg/ml + 4.0 Lenoir 10 manual dv, n
Palumbo 2015 9 ws V 5(5) 47 35-58 LS t + NaCl 0.05% 1:100 000 + 2.0 . sp x neg c (3x), d (2x)
Rubino 2015 8 ws V 10(10) . . AFT Breast f + R 20ml 2%c 0.5ml 1:200 000 →2.0 Coleman 10 manual c, d
→3.0 Mercedes 60 manual c, d 
Human processed fat- to-animal transplantation
Ramon 2005 11 bs A 1 (1) 32 32 LS b  + R 20ml 2% 1ml   - 2.0 10 . c , g
Smith 2006 10 bs A,V 3 (3) . . LS a  + R 30ml 1% 1mg in 1 ml  - . Coleman → 10 → manual c, wc, w (2x), n
    → sp → sp c, wc, w (2x), n
Kurita 2008 10 ws,bs A,V 8 (8) . 21-38 . a, t  + . . . . . Lipokit 50 sp dv (5x), n
Minn 2010 7 bs A,V . . . AFT Breast a  + R 50ml 1% 1 ml 1:1000  + 2.0 . 10 . c, g, s
Fisher 2013 9 ws A,V 1 (1) 57 57 LS t . . . . . . → Shippert → TT →-0.57 atm c, dv, g
    →Coleman → 10 →. c, dv, g
Hoareau 2013 10 ws A,V 9 (9) 43 (9) . LS .  + R 40ml 2% 1mg/L  - 2.0 Inex 10 <2cc neg c (6x), d
Ansorge 2014 12 ws A,V 10 (9) 41(9) 30-35 LS a  + R 50mg 1% 1ml 1:1000  - 3.3 VentX sp 0,5 atm neg c, d, dv
Salinas 2014 7 . A,V 9 (9) 48 (12) 29-63 LS a,f,t . . . . . 4.0 Mentor  . 1atm neg c, g
Human processed fat-to-human transplantation
Butterwick 2002 8 ws H 14 (14) 54 (.) 41-64 AFT Hands h,k,t  + NaCl 50ml 1% 1 ml 1:000  + 2.6 Klein 10 2cc neg c, n
Khater 2008 7 bs H,V 30 (26) . 15-47 AFT Face t . . . . . 2.6 . 10 . c, w
Khater 2009 10 bs H,V 51 (51) 33 (2) 16-55 AFT Face t . . . . . 2.6 . 10 <2cc neg c, w
Ferraro 2011 7 bs H,V 30 (.) . 30-50 AFT Buttock h,k,t . . . . . 3.0 . 20 x neg c (3x), d
Botti 2011 10 ws H 25 (21) 46(.) 21-72 AFT Face a,k,t  + NaCl 0.25% d 1:500 000  + 2.0 . 10 <2cc neg c, s
Asilian 2014 11 bs H 32 (.) . 35-50 AFT Face .  + R 0.05% 1:1000 000  - 2.0 10 <2cc neg c, s
Mestak 2014 9 bs H 30 (30) 38 (.) 28-62 AFT Breast a,f,t  + NaCl 1 ml  - 3.0 Mercedes 60 . c, dv
Gerth 2014 9 bs H 26(26)a 55 (11) 34-70 AFT Face a,t  + . 0.5% 1: 200 000  - 3.0 .  . 15 cc neg c, dv
or 0.25% or 1:400.000
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Animal processed fat  in vitro
Gonzalez 2007 8 ws V 5 rats . . AFT f  + R . . . 2;3 . 10/20/60 x neg d, g
Piasecki 2007 7 ws V x mice . . LS t . . . . . 1.2 . 5 5cc neg c (8x), d, g
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Huss 2002 8 ws V 8 (.) . . LS a,b . . . . . 5.0/6.0 Toomey 50 . w, wc
Rohrich 2004 8 ws V 5 (.) . . . a,f,k,t  + . . . . . Coleman 10 . c, n
Rose 2006 9 bs V 22 (.) . . AFT  a  + NaCl 50ml 1% 1 ml 1:000  + . Coleman 10 manual c, d
Kim 2009 8 ws V 8 (.) 32 (6) . LS a  + HS 20ml 2% 0.5ml 0.1%  - 1.2 Coleman . . c (8x), n
Conde-Green, b 2010 10 ws V 20 (20) . 28-64 LS a  + NaCl 1: 500 000  - 3.0 Richter 10 manual c, d, w
Conde-Green, a 2010 9 ws V 10 (10) . 35-58 LS a  + NaCl 1: 500 000  - 3.0 10 . c, d 
Herold 2011 8 ws V 9(5) 40 (.) 14-74 LS a,b,h  + NaCl 1ml 1:1000  + 3.0 Coleman → TT →-0.38 atm c, dv, n
→ 10 → <2cc neg c, dv, n
Pulsfort 2011 8 ws V 13 (11) 47 (11) . AFT/LS .  + NaCl 12.5ml 1% b 1:200 000  - 2.0 Coleman 10 . c (7x), n
Duman 2013 7 ws V . . . LS a  + NaCl 1:500 000  - . Lipokit 50 sp d, dv
Zhu 2013 10 ws V 22 (22) 45 (12) 24-64 . a,f,h . . . . . . . . . c, d, dv, n
Kamel 2014 8 ws V 20 (20) 31 (1) 20-41 LS a,t  + R 30ml 1% 1mg  - 3.0 60 → manual c, g
→ 2-3 atm c, g
Pfaff 2014 8 ws V 5 (3) 38 (24) 12-68 . a  + 10ml 1% 1:100 000  - . . 10 manual c, g
Iyyanki 2015 8 ws V 19(19) 51(10) 41-61 AFT Breast a, b, f . . . . . 3.0 Coleman 10 manual c, n
Osinga 2015 8 ws V 6(3) . . LS a + NaCl 0.91mg/ml 1.8µg/ml + 4.0 Lenoir 10 manual dv, n
Palumbo 2015 9 ws V 5(5) 47 35-58 LS t + NaCl 0.05% 1:100 000 + 2.0 . sp x neg c (3x), d (2x)
Rubino 2015 8 ws V 10(10) . . AFT Breast f + R 20ml 2%c 0.5ml 1:200 000 →2.0 Coleman 10 manual c, d
→3.0 Mercedes 60 manual c, d 
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Ramon 2005 11 bs A 1 (1) 32 32 LS b  + R 20ml 2% 1ml   - 2.0 10 . c , g
Smith 2006 10 bs A,V 3 (3) . . LS a  + R 30ml 1% 1mg in 1 ml  - . Coleman → 10 → manual c, wc, w (2x), n
    → sp → sp c, wc, w (2x), n
Kurita 2008 10 ws,bs A,V 8 (8) . 21-38 . a, t  + . . . . . Lipokit 50 sp dv (5x), n
Minn 2010 7 bs A,V . . . AFT Breast a  + R 50ml 1% 1 ml 1:1000  + 2.0 . 10 . c, g, s
Fisher 2013 9 ws A,V 1 (1) 57 57 LS t . . . . . . → Shippert → TT →-0.57 atm c, dv, g
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Human processed fat-to-human transplantation
Butterwick 2002 8 ws H 14 (14) 54 (.) 41-64 AFT Hands h,k,t  + NaCl 50ml 1% 1 ml 1:000  + 2.6 Klein 10 2cc neg c, n
Khater 2008 7 bs H,V 30 (26) . 15-47 AFT Face t . . . . . 2.6 . 10 . c, w
Khater 2009 10 bs H,V 51 (51) 33 (2) 16-55 AFT Face t . . . . . 2.6 . 10 <2cc neg c, w
Ferraro 2011 7 bs H,V 30 (.) . 30-50 AFT Buttock h,k,t . . . . . 3.0 . 20 x neg c (3x), d
Botti 2011 10 ws H 25 (21) 46(.) 21-72 AFT Face a,k,t  + NaCl 0.25% d 1:500 000  + 2.0 . 10 <2cc neg c, s
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Table 4. Details processing techniques per study
First author Year
Centrifugation force and 
time reported in study
(Calculated) Relative 
centrifugal force (xg) Other techniques
Animal processed fat in vitro
Gonzalez 2007 - - decantation; cotton towel (both 
50g 5 min centrifugation)
Piasecki 2007 500,1000,1500,2000rpm 3 
min;1000rpm 1,2,3,5,10 min
57xg, 228xg, 514xg, 913xg decantation 15min; mesh gauze  
rinsed with 5cc ringer 
Human processed fat in vitro
Boschert 2002 50g 2,4,6,8 min 50ig -
Huss 2002 wash + 200g 5min 200xg 2-4 times saline wash
Rohrich 2004 500g 2 min 500xg no treatment
Rose 2006 3000rpm 3 min 6000xg decantation; saline wash
Kim 2009 1500,3000,5000rpm 1,3,5 min 553xg, 2214xg, 6149xga no treatment
Conde-Green, b 2010 3000rpm 3 min 1150xga decantation; saline wash 
Conde-Green, a 2010 3000rpm 3 min 1150xga decantation 30min
Herold 2011 920g 3min, 1840g 3min 920xg, 1840xg no treatment; TissueTrans filtration
Pulsfort 2011 1000,1500,3000, 5000,7500,10.000, 
15.000rpm (no duration reported)
92xg, 206xg, 825xg, 2292xg, 
5157xg, 9168xg, 20.627xg
no treatment
Duman 2013 Lipokit® centrifugation 4000rpm 8min . no treatment
Zhu 2013 3000rpm 3min 1200xg no treatment;  decantation 20min; 
Puregraft® 250; Puregraft® 850
Kamel 2014 1000rpm 3min . mesh gauze without wash
Pfaff 2014 1500rpm 3min . Telfa rolling
Iyyanki 2015 3200rpm 2-3min . no treatment
Osinga 2015 - - no treatment; Shuffling though 3-way stoplock
Palumbo 2015 90g, 400g, 1500g 3min 90xg, 400xg, 1500xg decantation 10,20,30 min
Rubino 2015 3000rpm 3 min . no treatment; decantation 30min
Human processed fat -to-animal transplantation
Ramon 2005 1500rpm 2x5 min . cotton gauze 10min
Smith 2006 500g 2min;  ringer wash + 500g 
2min; saline  wash + 500g 2min
500xg no treatment; ringer wash; saline wash 
Kurita 2008 Lipokit® centrifugation 
400,700,1200,3000,4200g 3 min
400xg, 700xg, 1200xg, 
3000xg, 4200xg
no treatment
Minn 2010 1800g 3 min 1800xg cotton gauze, metal sieve
Fisher 2013 3000rpm 3 min 1200xg cotton gauze; Tissuetrans filtration®
Hoareau 2013 100g 1s,1min; 400,900g 1min; 




Ansorge 2014 1200g 3 min 1200xg decantation 10min; Revolve system™
Salinas 2014 1200g 3 min 1200xg mesh gauze
Human processed fat -to-human transplantation
Butterwick 2002 3600rpm 3 min . no treatment
Khater 2008 3000rpm 3 min . saline wash
Khater 2009 3400rpm 3 min . saline wash
Ferraro 2011 3000rpm 3 min (1300rpm 5 min 
and 500rpm only in vitro analysis)
1500xg (250xg and 50xg 
only in vitro analysis)
decantation
Botti 2011 3000rpm 3 min . metal sieve + saline
Asilian 2014 3400rpm 3 min . metal sieve + saline
Mestak 2014 3000rpm 3 min 1150xga Puregraft® 250
Gerth 2014 unknown . Puregraft® 250, Purgraft®850
- no technique in this category; . no RCF calculation possible based on unknown centrifuge radius and/or RPM, insufficient data reported to calculate 
relative centrifugal force; a, calculated relative centrifugal force based on the formula RCF=1.12*10-5 * r * rpm2. RCF= relative centrifugal force; r = radius 
of the centrifuge in centimeters reported in the article; rpm = revolutions per minute reported in the article. 
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Processing techniques
Thirty-three studies applied some form of centrifugation (Table 3 and 4). The relative centrifugal 
force could not be generated from 11 studies due to insufficient information about the 
centrifuge. Eight studies used different types of centrifugation times and/or forces. Decantation 
as a processing method was applied in 15 studies, the gauze/towel in 10, devices in 11, and 
metal sieve in 3. Just washing was reported in 5 studies and a combination of washing and 
centrifugation in 4 studies.
Cell viability in vitro
Centrifugation time
Differences centrifugation time (2, 4, 6 or 8 minutes) at 50xg did not affect viability in one 
study.24 An other study reported a reduction in the number of viable cells after centrifuging for 
5 minutes (at three different speeds, approximately 553xg, 2214xg, and 6149xg).25
Centrifugation forces
The number of viable cells were reduced with an increase in relative centrifugal force, above 
6149xg 25 and viable cells dropped between 228xg and 514xg 26. In contrast, other studies 
did not find a reduction in the number of viable cells with an increase in centrifugation forces 
(above 20.627xg 27 and 4200xg 28). In another study, viability was not affected by higher 
centrifugation forces, but more apoptotic and fewer necrotic cells were observed at 1500xg 
for 3 minutes compared to 50xg for 10 minutes and 250xg for 5 minutes.29
Centrifugation versus no centrifugation/decantation
Centrifugation resulted in significantly fewer intact cells30-32 or more altered cells33 compared to 
decantation. In contrast, one study found significantly better viability after centrifugation (57xg 
and 228xg 3min) and decantation26 compared to the negative control whereas one study did 
not find a difference in viability34 between centrifugation and the negative control.
Gauze/towel
Two studies reported a significantly higher number of viable cells using the mesh gauze 
technique compared to centrifugation (at 1000 and 1500 rpm 3 min, no RCF available).35,36 
Two other studies reported better viability with the gauze/towel technique compared to no 
treatment26 and decantation37. In another study, no significant difference was found regarding 
viability between centrifugation (1800xg 3 min) and mesh gauze.38 Additionally, both 
centrifugation and mesh gauze had significantly higher absorbance readings than the metal 




Adipocyte viability after processing with the TissueTrans® system (Shippert Medical Technology 
Corp Centennial, CO, USA) was 60%, which was significantly worse than after centrifugation 
(74% at 920xg 3min, 81% at 1840xg 3min).39 Lipokit® centrifugation (Medikan Corp., Seoul, 
Korea) showed histologically small groups of adipocytes, while large intact adipocytes were 
present in the control intervention samples after centrifugation.40 On the other hand, Puregraft® 
(Cytori Therapeutics Inc, San Diego, CA, USA), a closed wash/filter system, gave significantly 
better adipocyte viability than non-processed fat and centrifuged fat.41
Wash with/or without centrifugation
Washing showed, histologically, more pre-adipocytes than with centrifugation.42 Although 
washing combined with centrifugation resulted in lower viability compared to sedimentation30, 
washing without centrifugation43,44 or centrifugation only30,44 this lower viability trend was not 
significant in all studies.
Adipose derived stromal/stem cells (ASC) or stromal vascular fraction (SVF)
Different studies evaluated the ASC and SVF count between centrifugation and no treatment/
decantation. The results varied and were generally inconsistent which technique performed 
best (Table 5).28,29,31,32,45,46 Two studies found significantly higher ASC counts in the pellet of 
the centrifuged lipoaspirate than relating to the middle layer of the centrifuged lipoaspirate. 
31,32Two studies reported  significantly better results for the gauze/towel technique compared 
with centrifugation based on ASC number47 or SVF36. On the other hand, one study used a 
more strictly ASC marker profile and did not find significant differences in ASC count between 
the mesh gauze technique and centrifugation.48
Growth factors
One study did not find significant difference in the relative density unit of a broad variety of 
growth factors in lipoaspirates when comparing centrifugation to a closed wash/filter device 
(Zhu et al., 2013).41 In another study, at 24 hours after injection in mice significantly higher 
concentrations of IL-6 and MCP-1 were found after centrifugation at 900xg for 3 minutes 
compared to centrifugation at 400xg for 1 minute and decantation.49 No significant differences 
were found one week after injecting into mice.
Animal models: Graft volume and histology
All animal studies used xenografts (human fat transplanted into athymic animals, Table 6). 
Three out of seven studies reported a significant difference in volume or graft weight related to 
the different processing methods; these three studies also had shorter follow up times. Lipokit® 
centrifugation demonstrated significantly higher graft weight than no centrifugation.28 A wash 
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filter device (Revolve system™, LifeCell Corp, Bridgewater, NJ, USA) and centrifugation had 
significantly better graft take than decantation, 73% and 68% respectively, compared to 38% 
of the fat weight before injection.50 On the other hand in another study, the gauze/towel 
method gave significantly better results in graft volume with 70% retention compared to 47% 
retention after centrifugation.47










Kurita 2008 c, n SVF . no n > c 
Conde-
Green, b




2010 c, d ASC, SVF 45-34+105+ no c(p) >d, 
c(m)
Ferraro 2010 c, n ASC 34+90+105+ yes c > n
Duman 2013 dv, n SVF . no dv > n
Fisher 2013 c, g SVF . no g > c
Pfaff 2014 c, g ASC 73+105+, 73+44-, 73+90-,
90+44+
no g > c
Salinas 2014 c, g ASC 90+73+105-45- no g = c 
Iyyanki 2015 c,n ASC, SVF 11b- 45- 34+ D7FIB+ 90+ yes c > n (only 
SVF)
Osinga 2015 dv, n SVF . yes dv = n
Palumbo 2015 c,d ASC, SVF 45-105+90+ yes c = d
. not reported; m, middle layer of the centrifuged lipoaspirate; p, pellet of the centrifuged lipoaspirate; processing category used in the 
study; c, centrifugation; d, decantation; dv, device; g, gauze/towel; n, negative control; s, metal sieve; wc, washing+centrifugation; 
w, washing only; = no difference reported between used processing categories; > significant difference reported in advantage of the 
category in front of the > symbol.
Histologically, only a few differences were found in  animal recipient sites of fat grafts. One 
study found less fibrosis using gauze/towel versus centrifugation.51 Another study found 
no differences using the gauze/towel technique related to centrifugation, but found less 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Human models: graft volume and patients’ satisfaction
Eight studies covered autologous fat transfer in humans (Table 7). Five studies reported on 
facial augmentations, whereas three studies on hands, buttocks or breast augmentation. None 
of the studies used the gauze/towel technique. Only one study objectified different processing 
methods with regard to volume retention in humans. In this study, a significant better volumetric 
outcome (41.2% retention; SD 24.4) was found using a closed wash/filter device (Puregraft®) 
compared to centrifugation (31.8% retention; SD 20.3) in a historical control group.52
Patients’ satisfaction was comparable with the outcome of objective observers. Two studies 
reported that centrifugation resulted in higher satisfaction than no centrifugation in hands 
and buttocks.29,53 Washing was shown to be superior to centrifugation concerning patient 
satisfaction after facial augmentation.42,54 In two studies no significant difference was found 
in patients’ satisfaction between centrifugation, the use of the metal sieve technique and the 
closed wash/filter device.55,56
DISCUSSION
The vast majority of the 35 studies included in this systematic review analyzed centrifugation as 
a processing technique. Centrifugation is a commonly applied method in fat graft processing 
and usually serves as the gold standard. However, this systematic review demonstrates that 
the different processing techniques prove to be superior on several and diverse aspects. 
Especially with regard to cell viability, centrifugation resulted in more damaged adipocytes 
than other processing techniques. Both laboratory and animal studies showed that the 
gauze/towel technique and some devices based on permeability principles performed 
better than centrifugation for adipocyte viability, ASC count, volume retention and histology. 
Unfortunately, the gauze/towel technique was not used in all the eight clinical studies. As the 
survival mechanism of fat grafts in humans is not fully understood (yet), it is not exactly clear 
which of the evaluated in vitro outcome variables is crucial for the optimal survival of fat grafts.
Until recently, the fat graft survival theory by Peer was commonly accepted.57 This theory 
stipulates that grafts tend to survive better when transplanted as complete cell identities in 
favorable transplantation niches. Disregarding favorable transplantation niches supposedly, 
higher numbers of damaged results in lower retention of fat grafts. Accordingly low graft 
survival can be linked to centrifugaton, because centrifugation is known to result in the highest 
percentages of damaged adipocytes. In contrast, the atraumatic gauze/towel technique 
appears to perform better regarding adipocyte viability. Unfortunately, data concerning 
volume retention in animal and human studies is lacking to confirm this survival theory.
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Recently, new theories posed stating the interaction between the different components of fat 
grafts, and not the viability of adipocytes, is the principal factor in fat graft survival. One theory 
states that existing adipocytes die shortly after transplantation and new adipocytes will grow 
from stem or progenitor cell proliferation, the so-called compensatory proliferation.58,59 Some 
recent articles presume that poor microvascular circulation conditions trigger ASCs to induce 
angiogenic growth factors like VEGF.11,60 In this respect, the facilitation of the revascularization 
of the graft by angiogenic growth factors, and not the stem cells, will result in better long term 
survival. The highest numbers of ASCs in this review were in the fat processed with the gauze/
towel technique and in the pellets post-centrifugation.
Although the opinion about the survival theory has changed, the most recent studies in this 
review focus on other endpoints than viability, such as ASC and growth factors in vitro. 
However, it is still not proven that these laboratory outcome variables result in better fat 
survival in humans. Of the 35 included studies, only one measured volume retention in humans 
in relation to processing techniques.52 In that study, volume retention of the lipoaspirate was 
higher after processing with a closed filter device than after centrifugation as measured by 3D 
stereophotogrammetry. Unfortunately, the proportions of adipocytes, ASCs and growth factors 
in the fat graft after both processing methods were not measured.
Aside from the quest for the best processing technique, recent studies predominantly focus on 
lipoaspirate enrichement as well as ASCs or SVF before injection, the so-called cell-assisted 
lipotransfer. Studies on this technique showed better fat survival in enriched fat grafts compared 
to animals controls10,61,62 and human63. These results further indicate that ASCs appear to 
play an important role in fat grafting. Although enrichment of the fat graft seems to result in a 
powerful improvement of the number of ASCs, efficient methods for cell assisted lipotransfer 
(isolation and supplementation) in clinical practice are still lacking.
It is still unclear whether the use of an optimal processing technique resulting in a slightly higher 
level of ASCs gives a significantly higher residual volume. Studies performing cell-assisted 
lipotransfer used extremely high ASC counts. For example, the study performed in humans, 
used a 2000 times higher ASC level than found in under physiological conditions.63 In contrast 
to cell-assisted lipotransfer with high ASCs numbers, another study reported that human grafts 
with a physiologically higher proportion of ASCs resulted in greater survival in athymic mice.64 
In that study, small differences in ASCs led to significant differences in volumetric outcome.
Both the studies63,64 used the Coleman method (centrifugation) as a processing technique. 
The middle layer of the centrifuged lipoaspirate was suboptimal for adipocyte viability and 
ASC numbers regarding the included articles in this review. Further research is necessary to 
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determine whether other processing techniques, other than centrifugation, can increase the 
number of viable adipocytes and ASCs in processed lipoaspirates, thereby improving long 
term survival of fat grafts in humans.
This review was not without limitations. The great variation in outcome variables, and the 
development of a variety of processing method, do not allow for a straightforward answer as 
to which processing technique is the best. Eight categories and seven outcome variables still 
remain, even after simplifying the outcome variables and processing techniques. Regarding 
centrifugal forces, a relative centrifugal force could not be extracted in eleven studies because 
of insufficient information, thereby making comparison impossible. Moreover, before fat 
processing takes place, other steps and decisions such as infiltration solution, size of cannulas 
and negative harvesting pressure may impact outcome.6 Poor methods and materials 
description in the included studies made grouping impossible.
CONCLUSION
Centrifugation was the most commonly analyzed processing technique in this systematic review. 
Processing techniques using permeability principles were superior above the centrifugation 
technique in in vitro and animal studies in terms of viability, number of ASCs and fat graft 
retention. Such evidence of the superiority of these processing techniques is still missing in 
human studies. Clinically, there is no evidence of any best fat processing technique based on 
the results reported in the included studies, mainly due to the lack of evidence in humans and 
the great diversity in methods and outcome variables applied in these studies.
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Appendix 1. Search terms
Search term Pubmed:
((lipofilling[Title/Abstract]) OR (“fat graft*”[Title/Abstract]) OR (“fat transfer”[Title/Abstract]) OR (“fat 
transplant*”[Title/Abstract]) OR (“Transplantation, Autologous”[Mesh] AND fat [Title/Abstract]) OR 
(“Subcutaneous Fat/transplantation”[Mesh])) AND ((process* [Title/Abstract]) OR (“Tissue and Organ 
Harvesting/methods”[Mesh]) OR (“centrifugation”[Mesh]) OR (centrifugation [Title/Abstract]) OR (gauze [Title/
Abstract]) OR (wash* [Title/Abstract]) OR (sedimentation [Title/Abstract]) OR (decant* [Title/Abstract]) OR 
(mesh [Title/Abstract]) OR (sieve [Title/Abstract]) OR (towel [Title/Abstract]) OR (device [Title/Abstract]))
Search term Embase:
(lipofilling:ab,ti OR ‘fat graft’: ab,ti OR ‘fat transplantation’:ab,ti OR ‘autologous fat 
transplant’:ab,ti OR ‘fat transfer’:ab,ti ) AND (‘harvesting’:ab,ti OR proces:ab,ti OR 
‘centrifugation’/exp OR ‘centrifugation’:ab,ti OR gauze:ab,ti OR mesh:ab,ti OR towel:ab,ti 
OR ‘wash’:ab,ti OR ‘sedimentation’:ab,ti OR sieve:ab,ti OR device:ab,ti)
Search term Cinahl:
1. lipofilling OR fatgraft OR fat transplantation OR subcutaneous fat 
transplantation OR autologous fat transplantation   OR fat transfer
2. process OR harvesting OR centrifugation OR gauze OR mesh OR towel OR 
wash OR sedimentation OR decantation OR sieve OR device
3. #1 AND #2
Search term Cochrane Library:
(lipofilling or fat transfer or fat transplantation or fat graft) AND (process* or centrifugation or 
sedimention or gauze or mesh or towel or wash* or sedimentation or decant* or sieve or device)
42
Chapter 2


















































































































Ansorge et al, 2014 1 1 1 1 1 1 1 1 1 1 1 1 12
Ramon et al, 2005 1 1 1 1 1 1 1 1 1 1 1 11
Asilian et al, 2014 1 1 1 1 1 1 1 1 1 1 1 11
Condé-Green et al, 2010 1 1 1 1 1 1 1 1 1 1 10
Botti et al, 2011 1 1 1 1 1 1 1 1 1 1 10
Kurita et al, 2008 1 1 1 1 1 1 1 1 1 1 10
Hoareau et al, 2013 1 1 1 1 1 1 1 1 1 1 10
Smith et al, 2006 1 1 1 1 1 1 1 1 1 1 10
Khater et al, 2009 1 1 1 1 1 1 1 1 1 1 10
Rose et al, 2006 1 1 1 1 1 1 1 1 1 9
Condé-Green et al, 2010 1 1 1 1 1 1 1 1 1 9
Fisher et al, 2013 1 1 1 1 1 1 1 1 1 9
Mestak et al, 2014 1 1 1 1 1 1 1 1 1 9
Gerth et al, 2014 1 1 1 1 1 1 1 1 1 9
Palumbo et al 2015 1 1 1 1 1 1 1 1 1 9
Zhu et al, 2013 1 1 1 1 1 1 1 1 8
Butterwick et al, 2002 1 1 1 1 1 1 1 1 8
Herold et al, 2011 1 1 1 1 1 1 1 1 8
Kamel et al, 2014 1 1 1 1 1 1 1 1 8
Pulsfort et al, 2011 1 1 1 1 1 1 1 1 8
Kim et al, 2009 1 1 1 1 1 1 1 1 8
Gonzalez et al, 2007 1 1 1 1 1 1 1 1 8
Pfaff et al, 2014 1 1 1 1 1 1 1 1 8
Huss et al, 2002 1 1 1 1 1 1 1 1 8
Rubino et al, 2015 1 1 1 1 1 1 1 1 8
Boschert et al, 2001 1 1 1 1 1 1 1 1 8
Rohrich et al, 2004 1 1 1 1 1 1 1 1 8
Iyyanki et al 2015 1 1 1 1 1 1 1 1 8
Osinga et al 2015 1 1 1 1 1 1 1 1 8
Salinas et al, 2014 1 1 1 1 1 1 1 7
Ferraro et al, 2011 1 1 1 1 1 1 1 7
Khater et al, 2008 1 1 1 1 1 1 1 7
Duman et al, 2013 1 1 1 1 1 1 1 7
Piasecki et al, 2007 1 1 1 1 1 1 1 7
Minn et al, 2010 1   1 1   1     1 1   1 7
Shiffman et al  2001 * 1 1 1 1 1 1 6
Guijarro-Martínez et al, 2011* 1 1 1 1 1 1 6
Mikus et al, 1995 * 1   1     1     1 1     5
  34 17 38 33 10 37 13 1 36 36 32 32
The items are scored 0 (not reported or inadequate reported) or 1 (reported and adequate). The ideal score for comparative studies is 12. Three studies 
with a total MINORS score of 6 or lower are not included in the ranking list.
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